What Reviews May Miss About Prolonged Grief Disorder
When targeted evidence gets diluted, effective treatments for prolonged grief disorder may be harder to see—and use.
By
Kerri Miller
April 6, 2026
Clinical Scorecard: What Reviews May Miss About Prolonged Grief Disorder
At a Glance
Category Detail
Condition Prolonged Grief Disorder (PGD) Key Mechanisms Grounded in dual process coping, attachment, self-determination, and emotion regulation theories. Target Population Individuals aged 20 to 93 years experiencing prolonged grief. Care Setting Clinical settings providing psychotherapy and bereavement interventions.
Key Highlights
71% response rate for PGD-specific interpersonal psychotherapy in clinical trials. Moderate strength of evidence for psychotherapy's positive effects on grief symptoms. PGD is recognized in DSM-5-TR and ICD-11 with validated diagnostic tools. PG-13–Revised scale score of 30 or higher indicates need for PGD-specific treatment. Digital grief interventions show promise with sustained effects at 3-month follow-up. Guideline-Based Recommendations
Diagnosis
Use PG-13–Revised scale for assessment of PGD. Management
Implement PGD-specific psychotherapy interventions. Monitoring & Follow-up
Evaluate treatment response and symptom reduction over time. Risks
Potential dilution of evidence for PGD-specific therapies due to heterogeneous study grouping. Patient & Prescribing Data
Adults aged 20 to 93 years experiencing prolonged grief.
Targeted psychotherapy has shown efficacy in randomized trials.
Clinical Best Practices
Differentiate PGD-specific interventions from general grief therapies in systematic reviews. Consider digital interventions as adjuncts to traditional therapies. References
